India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is the treatment for knee pain? The knee joint is one of the largest and most complex joints in the human body. It plays a key role in activities such as supporting body weight, daily walking, running and jumping. But with age, due to wrong exercise methods, injuries or diseases, knee pain has become a problem for many people. Arthritis of the knee joint is a type of inflammatory disease in the joints and surrounding tissues of the human body, the disease process of which progresses slowly and usually appears after middle age. Its clinical symptoms include joint redness, swelling, warmth, pain, impaired mobility, and joint deformity. At the beginning of the disease, the problem appears in the cartilage of the joint and then it spreads to the bone below the cartilage, the nerve membrane and other tissues around the joint. The main feature is the erosion of the cartilage on the surface and edges of the joint and the formation of new bone. The origin process of this disease is c...